Reported by Kevin Dunleavy A former statistician at Pfizer and his associate have been charged (PDF) with insider trading, using advance information on a drug trial to make more than $350,000 from stock purchases they executed one day before the company announced trial results for COVID-19 drug Paxlovid. The U.S. attorney and the Securities and Exchange Commission […]